Insider Sentiment Summary: Drugs
Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Number of records: 205
CompanyIndustryLast Net Buy AmountPrevious Net Buy AmountChange
Blueprint Medicines CorpBiotechnology($5.58M)--($5.58M)  
Myriad Genetics IncDiagnostic Substances($7.70M)($95.28K)($7.61M)  
Kalvista Pharmaceuticals, Inc.Drugs - Generic--$12.70M($12.70M)  
Biomarin Pharmaceutical IncBiotechnology($15.12M)$3.70K($15.12M)  
Larimar Therapeutics, Inc.Biotechnology--$38.00M($38.00M)